The nuclear bile acid receptor FXR controls the liver derived tumor suppressor histidine-rich glycoprotein-Reference-Cited by-同舟云学术

The nuclear bile acid receptor FXR controls the liver derived tumor suppressor histidine-rich glycoprotein

Published:2014-11-13 Issue:11 Volume:136 Page:2693-2704
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Deuschle Ulrich¹,Birkel Manfred¹,Hambruch Eva¹,Hornberger Martin¹,Kinzel Olaf¹,Perović-Ottstadt Sanja¹,Schulz Andreas¹,Hahn Ulrike²,Burnet Michael²,Kremoser Claus¹

Affiliation:

1. Phenex Pharmaceuticals AG; Waldhofer Str. 104 69123 Heidelberg Germany

2. Synovo GmbH; Paul-Ehrlich-Str. 15 72076 Tübingen Germany

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference42 articles.

1. Immunolocalization of farnesoid X receptor (FXR) in mouse tissues using tissue microarray;Higashiyama;Acta Histochem,2008

2. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network;Bookout;Cell,2006

3. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis;Goodwin;Mol Cell,2000

4. Synthetic farnesoid X receptor agonists induce high-density lipoprotein-mediated transhepatic cholesterol efflux in mice and monkeys and prevent atherosclerosis in cholesteryl ester transfer protein transgenic low-density lipoprotein receptor (-/-) mice;Hambruch;J Pharmacol Exp Ther,2012

5. A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia;Evans;Am J Physiol Gastrointest Liver Physiol,2009

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of histidine-rich glycoprotein C633T single nucleotide polymorphism and recurrent miscarriage in Iranian women;Molecular Biology Reports;2024-07-13

2. The Association between Histidine-Rich Glycoprotein rs10770 Genotype and Recurrent Miscarriage in Iranian Women;BioMed Research International;2024-04-17

3. Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis;Frontiers in Immunology;2024-02-26

4. Review on chronic metabolic diseases surrounding bile acids and gut microbiota: What we have explored so far;Life Sciences;2024-01

5. FXR agonists for colorectal and liver cancers, as a stand-alone or in combination therapy;Biochemical Pharmacology;2023-06